Trial Profile
Personalized Theratyping Trial
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 18 Sep 2023
Price :
$35
*
At a glance
- Drugs Ivacaftor/lumacaftor (Primary) ; Ivacaftor/tezacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 08 Sep 2023 Planned End Date changed from 1 Jan 2024 to 1 Jan 2025.
- 08 Sep 2023 Planned primary completion date changed from 1 Sep 2023 to 1 Sep 2024.
- 30 Aug 2022 Planned End Date changed from 1 Jan 2023 to 1 Jan 2024.